← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (103)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 study (14)Clinical Trial (371)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1542)

• Sex-associated differences in routine inflammatory markers and neuromuscular ultrasound measurements in amyotrophic lateral sclerosis: a retrospective cross-sectional study. (2026/12/01) ♡
• Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue. (2026/10/01) ♡
• Network dynamics under neuronal degradation: A comparison between modular and small-world topologies. (2026/10/01) ♡
• Dietary intake and nutritional status in multiple sclerosis and associations with disease phenotype and management: A case-control study. (2026/10/01) ♡
• The many faces of the multiple sclerosis population in Canada. (2026/09/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Serum angiogenesis-hypoxia biomarkers in relapsing-remitting multiple sclerosis. (2026/09/01) ♡
• Upper limb rehabilitation in multiple sclerosis: A retrospective analysis of nine hole peg test and box and block test responses across disability levels and disease courses. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine. (2026/09/01) ♡
• Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tolebrutinib liver safety: A detailed overview. (2026/09/01) ♡
• Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis. (2026/08/25) ♡
• rs57494551 increases CXCR5 expression and IgM(+) CXCR5(+) B-cell infiltration in the portal area of primary biliary cholangitis. (2026/08/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The elusive link: EBV in MS. (2026/08/08) ♡
• Adoptive T-cell therapies in neuroinfectious and neuroinflammatory diseases. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocrelizumab: Pediatric First Approval. (2026/08/07) ♡
• Hyper-aging in systemic sclerosis: linking genome instability, mitochondrial dysfunction, and inflammaging to fibrosis. (2026/08/06) ♡
• Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis. (2026/08/06) ♡
• Retinal atrophy in multiple sclerosis is similar with extended versus standard interval natalizumab therapy. (2026/08/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles. (2026/08/04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Depressive symptoms in amyotrophic lateral sclerosis: associations with quality of life, disease progression and perceived social support-a German multicenter study. (2026/08/04) ♡
• Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis. (2026/08/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quantitative susceptibility mapping in neurodegenerative diseases: An umbrella review of iron-related biomarkers and mechanisms. (2026/08/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition. (2026/08/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Tolebrutinib in nonrelapsing SPMS: regulatory divergence and the limits of relapse based labels. (2026/08/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Preventive dietary and lifestyle strategies for neurodegenerative diseases: a comprehensive review. (2026/08/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Association of long-term outdoor air pollution exposure with incidence of Parkinson's disease, multiple sclerosis and motor neuron diseases: a systematic review and meta-analysis. (2026/08/01) ♡
• Early Upper Limb Motor Impairment in Multiple Sclerosis Across EDSS Levels: A Case-Control Study. (2026/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Comorbidities in multiple sclerosis: acquired hepatocerebral degeneration mimicking disease progression. (2026/07/31) ♡
• A lightweight method for regression-based normalization of the cross-sectional area for cervical spinal cord atrophy assessment. (2026/07/31) ♡
• Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial. (2026/07/30) ♡
• Evaluation of Dried Plasma Spot-Based Quantification of Glial Fibrillary Acidic Protein as a Disease-Associated Biomarker in Neuromyelitis Optica Spectrum Disorder. (2026/07/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination. (2026/07/28) ♡
• Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study. (2026/07/28) ♡
• Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination. (2026/07/27) ♡
• Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple Sclerosis. (2026/07/26) ♡
• Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis. (2026/07/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Psychiatric disorders in amyotrophic lateral sclerosis: a short note. (2026/07/23) ♡
• Potential Role of Nociceptin/Orphanin FQ in the Progression of Multiple Sclerosis. (2026/07/22) ♡
• The value of brain age as a transdiagnostic biomarker of neurodegeneration. (2026/07/22) ♡
• Tumor fat composition predicts response to everolimus and supports low-dose therapy in TSC-associated renal angiomyolipomas: a multicenter prospective study. (2026/07/22) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. (2026/07/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data. (2026/07/21) ♡
• Choroid plexus morphological and microstructural changes across inflammatory phenotypes in multiple sclerosis. (2026/07/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Induced pluripotent stem cell treatment for microglia replacement in progressive MS. (2026/07/21) ♡
• Acute Heart Failure in Advanced Systemic Sclerosis With Multiorgan Involvement. (2026/07/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autism and Neurodegeneration: Distinct Disorders or a Shared Biological Continuum? (2026/07/21) ♡
• Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression. (2026/07/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Overlapping multiple sclerosis and neuropsychiatric systemic lupus erythematosus with positive MOG-IgG: a case initially misdiagnosed as depression. (2026/07/20) ♡
• Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients. (2026/07/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Decoding the PI3K/Akt/mTOR-JAK/STAT signaling axis in multiple sclerosis: mechanistic crosstalk and therapeutic opportunities. (2026/07/17) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.